C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 37/06 (2006.01) A61P 37/08 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C12N 5/10 (2006.01) C12N 5/16 (2006.01) C12N 15/12 (2006.01) C12N 15/63 (2006.01) C12P 21/08 (2006.01) G01N 33/554 (2006.01) G01N 33/58 (2006.01)
Patent
CA 2344086
Immunization of human antibody-producing transgenic mice, which have been created using genetic engineering techniques, with AILIM molecule as an antigen resulted in various human monoclonal antibodies capable of binding to AILIM and capable of controlling a variety of biological reactions (for example, cell proliferation, cytokine production, immune cytolysis, cell death, induction of ADCC, etc.) associated with AILIM-mediated costimulatory signal (secondary signal) transduction. Furthermore, it has been revealed that the human monoclonal antibody is effective to treat and prevent various diseases associated with AILIM-mediated costimulatory signal transduction, being capable of inhibiting the onset and/or advancement of the diseases.
Hori Nobuaki
Tezuka Katsunari
Tsuji Takashi
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Japan Tobacco Inc.
LandOfFree
Human monoclonal antibody against a costimulatory signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal antibody against a costimulatory signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibody against a costimulatory signal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1557746